ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Patrick Burnett sold $713K of Arcutis Biotherapeutics, Inc.
Sold$712,621
$10.29Price
69,226Shares
−35%Stake
What ARQT did after the filing
- The stock from Tue, Nov 19 open, $9.33
- +56.7%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the Jan 3 close.
Traded Thu, Nov 14. Filed Mon, Nov 18, 7:04 PM ET, after the close. Returns use the Nov 19 open and the Jan 3 close. Not investment advice.